Diagnostic options · UAE

Gene Rearrangement tests in Dubai & UAE

Compare available Gene Rearrangement tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

800.00–1,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Rearrangement test prices

Showing 1–5 of 5 matching tests.

Gene Rearrangement diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1134 FIP1L1-PDGFRA Gene Rearrangement Detection Test This test detects the presence of the FIP1L1-PDGFRA gene fusion, a key marker for specific types of chronic eosinophilic leukemia and hypereosinophilic syndrome.	Whole blood (4 mL, EDTA) or bone marrow aspirate	12 days from sample receipt (Monday 11 AM cutoff)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FIP1L1-PDGFRA gene fusion", "Presence of specific gene rearrangement"] Parameters [] Preparation ["Inform physician of all medications, especially imatinib or corticosteroids", "Complete Genomics Clinical Information Requisition Form (Form 20)"] Indications ["Diagnosis of chronic eosinophilic leukemia (CEL)", "Diagnosis of hypereosinophilic syndrome", "Guiding imatinib therapy"] Measurement technique Confirm with laboratory Codes LOINC: 38288-2 ICD-10: D47.5 Clinical summary This test detects the presence of the FIP1L1-PDGFRA gene fusion, a key marker for specific types of chronic eosinophilic leukemia and hypereosinophilic syndrome.
TEST-2288 Inv(16)(p13q22) / t(16;16)(p13q22) Gene Rearrangement Qualitative PCR Test This test detects the presence or absence of the CBFB-MYH11 gene rearrangement, a specific genetic marker found in certain types of acute myeloid leukemia (AML).	Whole Blood or Bone Marrow Aspirate	Sample Mon/Thu by 11 am → Report Wed/Sat	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBFB-MYH11 gene rearrangement", "Presence of inv(16)(p13q22) or t(16;16)(p13q22) translocation"] Parameters [] Preparation ["No specific patient preparation required", "Sample collection must be performed in an accredited hospital facility"] Indications ["Diagnosis of AML", "Risk stratification in AML", "Minimal residual disease (MRD) monitoring in AML"] Measurement technique Confirm with laboratory Codes LOINC: 33680-6 ICD-10: C92.8 Clinical summary This test detects the presence or absence of the CBFB-MYH11 gene rearrangement, a specific genetic marker found in certain types of acute myeloid leukemia (AML).
TEST-1293 NTRK1 Gene Rearrangement Test This test identifies NTRK1 gene fusions in tumor tissue using FISH.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Biopsy Slides	7–8 Business Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NTRK1 gene fusions", "Presence of NTRK1 rearrangements"] Parameters [] Preparation [] Indications ["Patients with suspected or confirmed neoplasms where NTRK1 fusions are relevant", "Guiding targeted therapy with TRK inhibitors"] Measurement technique Confirm with laboratory Codes LOINC: 94496-2 ICD-10: C80.1 Clinical summary This test identifies NTRK1 gene fusions in tumor tissue using FISH.
TEST-1288 NTRK3 Gene Rearrangement Test This diagnostic test evaluates for the presence of rearrangements or fusions involving the NTRK3 gene within tumor tissue using Fluorescence In Situ Hybridization (FISH).	Formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks or fresh tissue in approved transport medium	7–8 business days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NTRK3 gene rearrangements", "Oncogenic fusions"] Parameters [] Preparation [] Indications ["Personalized cancer care", "Oncology", "Pediatric tumors", "Precision medicine", "Guiding targeted therapy with TRK inhibitors"] Measurement technique Confirm with laboratory Codes LOINC: 86553-5 ICD-10: C80.1 Clinical summary This diagnostic test evaluates for the presence of rearrangements or fusions involving the NTRK3 gene within tumor tissue using Fluorescence In Situ Hybridization (FISH).
TEST-2918 PML::RARA t(15;17)(q22;q12) Gene Rearrangement Quantitative PCR Test This diagnostic test evaluates the presence and quantity of the PML::RARA fusion transcript, a genetic marker specific for acute promyelocytic leukaemia (APL).	Whole blood	2 business days (sample Mon/Wed/Fri by 9 AM → report Tue/Thu/Sat)	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML::RARA fusion transcript", "t(15;17)(q22;q12) translocation"] Parameters [{"name": "PML::RARA Fusion Transcript Quantification", "reference_range": "Negative or low levels (specific threshold depends on laboratory standards)"}] Preparation ["No fasting required", "Provide a blood sample", "Provide a completed Genomics Clinical Information Requisition Form (Form 20)", "Include a list of current medications, especially anticoagulants"] Indications ["Diagnosis of acute promyelocytic leukaemia (APL)", "Remission assessment in APL", "Minimal residual disease (MRD) monitoring in APL", "Resistance detection during APL therapy"] Measurement technique Confirm with laboratory Codes LOINC: 33696-8 ICD-10: C92.4 Clinical summary This diagnostic test evaluates the presence and quantity of the PML::RARA fusion transcript, a genetic marker specific for acute promyelocytic leukaemia (APL).

Category overview

Gene Rearrangement: overview

Evaluating complex blood or lymph node abnormalities requires the highest level of precision, giving your medical team the foundational data needed to track malignant cellular growth accurately. Within our Molecular Diagnostics division, our Gene Rearrangement testing utilizes advanced PCR technology to assess the genetic uniformity and structural shifts in immune cell populations. Rather than acting as a definitive standalone diagnosis, this critical molecular data empowers your hematopathologist with the exact insights required to shape targeted, proactive medical guidance and oncology care plans. Trusted among the top diagnostic labs in Dubai and the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality alongside remarkably swift, accurate turnaround times. Gain actionable clarity for your health: review our gene rearrangement testing in the UAE below to book an appointment or consult our dedicated experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.